Navigation Links
Leading Clinical Technology Organization M2S Inc. Announces the Appointment of Jeffrey Yablon as Senior Vice President, Business Development
Date:4/15/2009

M2S Inc., a clinical technology organization providing image management services for biopharmaceutical and medical device clinical trials and clinical data registries, announced today that it has named Jeffrey Yablon as its new Senior Vice President, Business Development. In his new role at M2S, Mr. Yablon will be responsible for managing all M2S sales efforts and overseeing the marketing strategy of the rapidly expanding Clinical Trials Imaging, endovascular, and Clinical Data Registries services, in addition to the development and implementation of strategic partnerships.

(PRWEB) April 15, 2009 -- M2S Inc., a clinical technology organization providing image management services for biopharmaceutical and medical device clinical trials and clinical data registries, announced today that it has named Jeffrey Yablon as its new Senior Vice President, Business Development.

Mr. Yablon brings over 20 years of experience in the life sciences industry, including senior management roles in pharmaceuticals, drug safety, laboratory management, clinical research, medical imaging and clinical technology. Before joining M2S, Mr. Yablon held the position of Vice President, Sales and Marketing with Sciformix Corporation, a knowledge process outsourcing organization providing pharmacovigilance services to biopharmaceutical and biotech companies. Prior to that position, he held the position of Vice President of Global Business Development at Perceptive Informatics, the technology division of Parexel International. He was also Chief Operating Officer at ICON Laboratories, a division of ICON Plc. Mr. Yablon is a founder of several companies as well as a current instructor and course director at Stony Brook University, Center for Biotechnology in Stony Brook, NY. He began his career at TAP Pharmaceuticals and Abbott Laboratories, where he held various positions of increasing responsibility in sales and marketing. Mr Yablon received his MBA from the executive program at Fairleigh Dickinson University. In his new role at M2S, Mr. Yablon will be responsible for managing all M2S sales efforts and overseeing the marketing strategy of the rapidly expanding Clinical Trials Imaging, Endovascular, and Clinical Data Registries services, in addition to the development and implementation of strategic partnerships.

"Jeffrey has extensive experience and in-depth industry knowledge of the clinical research and informatics industry, and therefore will be a great asset to our organization," said M2S's CEO, Wes Chapman. "He is a well respected and established leader in the clinical trials community, and our clients will greatly benefit from his understanding of their drug and medical device challenges in the new economy. His leadership, combined with the M2S clinical expertise, highly efficient processes and advanced technologies, will continue to advance our market share in the clinical trials and patient data registries markets."

Mr. Yablon says, "I am excited to be part of a truly differentiated Clinical Technology Organization that is able to combine best-in-class technical infrastructure with superior clinical acumen that will directly impact cost, quality, and efficiency to benefit our clients. I look forward to playing a key role in the growth of M2S."

About M2S
M2S is a Clinical Technology Organization (CTO), providing high-quality, timely and cost-effective image data management services for clinical trial sponsors in the biopharmaceutical and medical device industries as well as clinical registry databases. For the past 10 years, M2S has managed, under protocol, over 150 million images from around the globe in all major therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com

###

Read the full story at http://www.prweb.com/releases/clinical/trials/prweb2324234.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Frost & Sullivan Recognizes CRi for Innovations Leading to Personalized Medicine
2. Western Governors University to Launch Nations First Competency-Based B.S. in Nursing Leading to RN Licensure
3. HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions
4. Nobel Prize Winner Professor Muhammad Yunus Leading Delegation From Bangladesh to World Health Care Congress to Advance Affordable Health Care Innovations
5. Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center
6. New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss deliver superior plaque removal compared to leading competitive products
7. The Nation's Leading Health Care Strategy Firm Launches Post-Merger Integration Practice
8. Versus Technology to Showcase Leading Enterprise Patient and Clinical Workflow Solutions at HIMSS 2009
9. Last step leading to blood cell formation elucidated
10. Leading Autism Care Provider Invites MPs to Meet Residents and Staff for World Autism Awareness Day
11. Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Leading Clinical Technology Organization M2S Inc. Announces the Appointment of Jeffrey Yablon as Senior Vice President, Business Development
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology: